Skip to main content
. 2019;20(12):3735–3746. doi: 10.31557/APJCP.2019.20.12.3735

Table 5.

Kaplan Meier Analysis of Clinicopathological Characteristics and c-Myc Nuclear Expression for Overall Survival (OS) 52 Patients and Disease Free Survival (DFS) of 48 Patients with MIUC of the Bladder

Parameter OS
DFS
p value* p value*
Gender 0.761 0.738
Males
Females
Variant of UC 0.409 0.449
Conventional
Sarcomatoid
Differentiation of UC** 0.453 0.367
Squamous
Absent
Pattern of tumor invasion
Nodular pattern 0.463 0.644
Present
Absent
Trabecular pattern 0.695 0.837
Present
Absent
Infiltrative pattern 0.158 0.223
Present
Absent
Bilharziasis 0.285 0.270
Present
Absent
Necrosis 0.509 0.194
Present
Absent
PNI 0.624 0.766
Present
Absent
LVI 0.060 0.548
Present
Absent
pT stage 0.050 0.449
T2a
T2b
T3a
T3b
T4a
pN stage 0.050 0.633
N0
N1
N2
M stage 0.011 Not Done ***
M0
M1b
Stage grouping 0.018 0.800 ****
II
Stage grouping 0.018 0.800 ****
IIIA
IIIB
IVB
c-Myc nuclear expression 0.161 0.272
High (>120)
Low (≤120)

LVI, lymphovascular invasion; PNI, perineural invasion; UC, urothelial carcinoma; * p value by Log Rank test; ** Glandular group was excluded from analysis as they were only 2 cases; *** Not Done as the patients with M1b stage developed metastasis at the time of operation (i.e. had no disease free survival period), so no comparison analysis could be performed; **** Comparison was done between stages II, IIIA and IIIB. IVB did not included.